Therapeutic administration of enrofloxacin in mice does not select for fluoroquinolone resistance in Campylobacter jejuni

Canadian Journal of Microbiology
G Douglas InglisRichard R E Uwiera

Abstract

Enrofloxacin is registered for therapeutic use in beef cattle to treat bovine respiratory disease in Canada. A murine model was used to experimentally examine the impact of therapeutic administration of enrofloxacin on fluoroquinolone resistance development in Campylobacter jejuni. Administration of enrofloxacin to mice via subcutaneous injection or per os routes resulted in equivalent levels of bioactive enrofloxacin within the intestine, but bioactivity was short-lived (<48 h after cessation). Enrofloxacin administration did not affect densities of total bacteria, Firmicutes, or Bacteroidetes in digesta and had modest impacts on densities of Enterobacteriaceae. All mice inoculated with C. jejuni NCTC 11168 became persistently colonized by the bacterium. Enrofloxacin reduced C. jejuni cell densities within the cecal and colonic digesta for all treatments, and densities shed in feces as a function of antibiotic duration. None of the C. jejuni isolates recovered from mice after administration of enrofloxacin (n = 260) developed resistance to ciprofloxacin regardless of method or duration of administration. Furthermore, only modest shifts in the minimum inhibitory concentration of the isolates by treatment were noted. The study f...Continue Reading

References

Oct 31, 1997·Journal of Pharmaceutical Sciences·C C Cester, P L Toutain
Feb 7, 1998·Journal of Veterinary Pharmacology and Therapeutics·L KaartinenS Räisänen
Nov 9, 2002·Journal of Veterinary Pharmacology and Therapeutics·C WiuffO Svendsen
Jun 6, 2003·Applied and Environmental Microbiology·G Douglas Inglis, Lisa D Kalischuk
Mar 19, 2004·The Journal of Antimicrobial Chemotherapy·Anne A DelsolJohn M Roe
Sep 17, 2004·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·S A JohnsonS Jackson
Jun 21, 2005·Regulatory Toxicology and Pharmacology : RTP·Agnes Perrin-GuyomardMary Bartholomew
Jul 22, 2005·Journal of Applied Microbiology·M D EnglenD A Dargatz
Sep 13, 2005·The Veterinary Journal·Marilyn MartinezRobert Walker
Oct 7, 2006·The Journal of Antimicrobial Chemotherapy·Meiguan YanQijing Zhang
Apr 27, 2007·Experimental Animals·Tomoe Ogino, Toshiro Arai
Dec 5, 2009·Foodborne Pathogens and Disease·Sangeeta RaoPaul S Morley
Nov 11, 2010·Journal of Veterinary Pharmacology and Therapeutics·J E GriffithM Govendir
Jun 28, 2011·Journal of Microbiological Methods·Tristano Bacchetti De GregorisJ Grant Burgess
Dec 20, 2011·Regulatory Toxicology and Pharmacology : RTP·Youngbeom AhnCarl E Cerniglia
Feb 15, 2013·Virulence·Nicole M Iovine
May 3, 2015·Applied and Environmental Microbiology·Jason L O'LoughlinMichael E Konkel
Jan 29, 2017·The Journal of Allergy and Clinical Immunology·Anna StrzępaMarian Szczepanik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.